RE: Larry Ellison14 Oct 2025 20:44
From the Times article
Ono, speaking alongside Lisa Flashner, the institute’s American chief operating officer, insists, though, there has been “no backpedalling” and having “impact” through commercialising science “will always be the founding principle. It’ll be integrated into the collective DNA of everyone recruited to the institute.”
He adds: “We anticipate multiple spin-offs in the not too distant future.”
The plans also include co-investing and collaborating with other companies, with profits invested back into the institute.
Current investments include becoming the largest shareholder in Oxford Nanopore Technologies, the FTSE 250 company that is a neighbour on the science park, through EIT Oxford Holdings, a California-based parent company.
Professor Hagan Bayley, a founder of Oxford Nanopore, is joining the institute as a principal scientist.
One ambition is to address the “valley of death” where start-ups fail or progress slowly because of a lack of scale-up capital. The funding gap has forced many of the UK’s most promising technologies and ventures to turn to the United States for finance and growth.